Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618216.RAY5dzy6fOcHEt_Ag7zT4D4VAAstXsKu8ALU8q9MsnoIM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618216.RAY5dzy6fOcHEt_Ag7zT4D4VAAstXsKu8ALU8q9MsnoIM130_assertion type Assertion NP618216.RAY5dzy6fOcHEt_Ag7zT4D4VAAstXsKu8ALU8q9MsnoIM130_head.
- NP618216.RAY5dzy6fOcHEt_Ag7zT4D4VAAstXsKu8ALU8q9MsnoIM130_assertion description "[In order to evaluate the possible participation of P-glycoprotein (Pgp)-mediated multidrug resistance (MDR) in medulloblastoma therapy and its correlation with prognosis, archival specimens were examined by immuno-histochemistry utilizing 3 monoclonal antibodies against Pgp and 6 cases by reverse-transcriptase polymerase chain reaction (RT-PCR) using MDR1-specific primers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618216.RAY5dzy6fOcHEt_Ag7zT4D4VAAstXsKu8ALU8q9MsnoIM130_provenance.
- NP618216.RAY5dzy6fOcHEt_Ag7zT4D4VAAstXsKu8ALU8q9MsnoIM130_assertion evidence source_evidence_literature NP618216.RAY5dzy6fOcHEt_Ag7zT4D4VAAstXsKu8ALU8q9MsnoIM130_provenance.
- NP618216.RAY5dzy6fOcHEt_Ag7zT4D4VAAstXsKu8ALU8q9MsnoIM130_assertion SIO_000772 8743996 NP618216.RAY5dzy6fOcHEt_Ag7zT4D4VAAstXsKu8ALU8q9MsnoIM130_provenance.
- NP618216.RAY5dzy6fOcHEt_Ag7zT4D4VAAstXsKu8ALU8q9MsnoIM130_assertion wasDerivedFrom befree-20150227 NP618216.RAY5dzy6fOcHEt_Ag7zT4D4VAAstXsKu8ALU8q9MsnoIM130_provenance.
- NP618216.RAY5dzy6fOcHEt_Ag7zT4D4VAAstXsKu8ALU8q9MsnoIM130_assertion wasGeneratedBy ECO_0000203 NP618216.RAY5dzy6fOcHEt_Ag7zT4D4VAAstXsKu8ALU8q9MsnoIM130_provenance.